drugset
Drugs / p.DOM-WT1-126
last change Feb 2013 re-read 3 minutes ago

p.DOM-WT1-126

Vaccine

Developed for
chronic leukemia · acute myeloid leukemia
Investigated by
Efficacy and Mechanism Evaluation (EME) Programme · Imperial College Healthcare NHS Trust · Inovio Pharmaceuticals · Leukemia Research Fund · Royal Devon and Exeter NHS Foundation Trust · University Hospital Southampton NHS Foundation Trust

Trials 1

today NCT01334060 · Ph 2
20112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT01334060 Feb 2011 → Feb 2013 acute lymphoblastic leukemia, acute promyelocytic leukemia, chronic leukemia University Hospital Southampton NHS Foundation Trust Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as p.DOM-WT1-126 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01334060 ↗
Modality Vaccine “DNA vaccines” NCT01334060 ↗
Route Intramuscular “The vaccines will be injected intramuscularly (im) followed by electroporation (EP) into separate locations.” NCT01334060 ↗